NASDAQ : EOLS
Evolus, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 7.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 496.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Evolus, Inc. (EOLS) reported revenue of 316.49M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 316.49M | 297.18M | 266.27M | 202.09M | 148.62M | 99.67M |
| Cost of Revenue | 106.33M | 100.07M | 83.97M | 64.51M | 58.84M | 43.53M |
| Gross Profit | 210.16M | 197.11M | 182.30M | 137.57M | 89.77M | 56.14M |
| Selling, General & Admin | 216.50M | 220.79M | 198.03M | 164.94M | 141.84M | 112.07M |
| Research & Development | 9.66M | 9.58M | 9.17M | 6.56M | 4.74M | 2.06M |
| Operating Expenses | 231.82M | 234.71M | 209.54M | 173.68M | 147.35M | 119.75M |
| Operating Income | -21.66M | -37.60M | -27.23M | -36.11M | -57.58M | -63.62M |
| Interest Expense | -16.22M | -19.69M | -18.73M | -13.83M | -9.10M | -1.40M |
| Interest & Investment Income | 1.32M | 1.93M | 3.26M | 860.00K | 119.00K | 1.00K |
| Other Non Operating Income (Expenses) | -112.00K | -539.00K | 127.00K | 696.00K | -9.00K | |
| EBT Excluding Unusual Items | -36.67M | -55.90M | -42.58M | -48.38M | -66.56M | -65.01M |
| Merger & Restructuring Charges | -1.44M | -1.44M | ||||
| Legal Settlements | 25.50M | |||||
| Other Unusual Items | 4.43M | 6.38M | -7.18M | -4.26M | -5.75M | -7.26M |
| Pretax Income | -33.68M | -50.96M | -49.76M | -61.51M | -74.32M | -46.77M |
| Income Tax Expense | 654.00K | 677.00K | 664.00K | 176.00K | 95.00K | 42.00K |
| Net Income | -34.33M | -51.64M | -50.42M | -61.69M | -74.41M | -46.81M |
| Net Income to Common | -34.33M | -51.64M | -50.42M | -61.69M | -74.41M | -46.81M |
| Shares Outstanding (Basic) | 65.19M | 64.47M | 62.02M | 56.92M | 56.07M | 49.77M |
| Shares Outstanding (Diluted) | 65.19M | 64.47M | 62.02M | 56.92M | 56.07M | 49.77M |
| EPS (Basic) | -0.53 | -0.80 | -0.81 | -1.08 | -1.33 | -0.94 |
| EPS (Diluted) | -0.53 | -0.80 | -0.81 | -1.08 | -1.33 | -0.94 |
| Free Cash Flow | -18.28M | -45.71M | -19.47M | -34.48M | -86.53M | -33.78M |
| Free Cash Flow Per Share | -0.28 | -0.71 | -0.31 | -0.61 | -1.54 | -0.68 |
| Gross Margin | 66.40% | 66.33% | 68.47% | 68.08% | 60.41% | 56.32% |
| Operating Margin | -6.84% | -12.65% | -10.23% | -17.87% | -38.74% | -63.82% |
| Profit Margin | -10.85% | -17.38% | -18.93% | -30.52% | -50.07% | -46.96% |
| Free Cash Flow Margin | -5.78% | -15.38% | -7.31% | -17.06% | -58.22% | -33.89% |
| EBITDA | -12.77M | -30.09M | -21.94M | -30.97M | -53.85M | -57.99M |
| EBITDA Margin | -4.04% | -10.13% | -8.24% | -15.33% | -36.24% | -58.18% |
| D&A For EBITDA | 8.89M | 7.51M | 5.30M | 5.13M | 3.72M | 5.62M |
| EBIT | -21.66M | -37.60M | -27.23M | -36.11M | -57.58M | -63.62M |
| EBIT Margin | -6.84% | -12.65% | -10.23% | -17.87% | -38.74% | -63.82% |
| Revenue as Reported | 316.49M | 297.18M | 266.27M | 202.09M | 148.62M | 99.67M |
| Advertising Expenses | 16.39M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 45.17M | 53.83M | 86.95M | 62.84M | 53.92M | 146.26M |
| Cash & Short-Term Investments | 45.17M | 53.83M | 86.95M | 62.84M | 53.92M | 146.26M |
| Accounts Receivable | 62.38M | 54.70M | 47.68M | 30.53M | 22.45M | 14.66M |
| Receivables | 62.38M | 54.70M | 47.68M | 30.53M | 22.45M | 14.66M |
| Inventory | 40.90M | 26.96M | 12.16M | 11.00M | 18.85M | 1.76M |
| Prepaid Expenses | 4.45M | 3.76M | 3.35M | 5.70M | 3.90M | 5.08M |
| Other Current Assets | 14.64M | 3.67M | 1.20M | 2.36M | 1.68M | 11.04M |
| Total Current Assets | 167.54M | 142.92M | 151.34M | 112.42M | 100.80M | 178.80M |
| Property, Plant & Equipment | 11.48M | 12.50M | 10.41M | 7.85M | 4.56M | 4.09M |
| Goodwill | 21.21M | 21.21M | 21.21M | 21.21M | 21.21M | 21.21M |
| Other Intangible Assets | 45.69M | 48.04M | 48.75M | 47.11M | 48.60M | 50.62M |
| Other Long-Term Assets | 2.10M | 1.20M | 858.00K | 409.00K | 2.81M | 2.76M |
| Total Assets | 248.02M | 225.87M | 232.57M | 189.00M | 177.98M | 257.48M |
| Accounts Payable | 44.48M | 23.36M | 9.24M | 4.27M | 8.94M | 6.09M |
| Accrued Expenses | 20.94M | 18.20M | 21.59M | 19.12M | 13.16M | 9.61M |
| Current Portion of Leases | 2.57M | 2.53M | 1.72M | 1.38M | 1.32M | 1.26M |
| Current Unearned Revenue | 11.59M | 11.55M | 14.45M | 11.03M | 9.01M | 7.93M |
| Other Current Liabilities | 19.15M | 19.67M | 15.96M | 12.49M | 14.08M | 32.76M |
| Total Current Liabilities | 98.73M | 75.31M | 62.96M | 48.29M | 46.51M | 57.66M |
| Long-Term Debt | 156.74M | 146.10M | 121.51M | 120.36M | 71.88M | 71.22M |
| Long-Term Leases | 5.49M | 6.37M | 6.75M | 4.81M | 1.22M | 2.26M |
| Long-Term Deferred Tax Liabilities | 15.00K | 28.00K | 6.00K | 27.00K | 22.00K | 40.00K |
| Other Long-Term Liabilities | 17.95M | 21.17M | 35.82M | 36.20M | 39.85M | 44.43M |
| Total Liabilities | 278.93M | 248.97M | 227.05M | 209.69M | 159.48M | 175.61M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 649.39M | 638.09M | 615.83M | 538.72M | 516.13M | 504.76M |
| Retained Earnings | -679.77M | -661.04M | -609.40M | -558.98M | -497.29M | -422.88M |
| Comprehensive Income & Other | -529.00K | -156.00K | -905.00K | -427.00K | -337.00K | |
| Shareholders' Equity | -30.90M | -23.11M | 5.52M | -20.69M | 18.50M | 81.88M |
| Total Liabilities & Equity | 248.02M | 225.87M | 232.57M | 189.00M | 177.98M | 257.48M |
| Total Debt | 164.80M | 155.00M | 129.98M | 126.55M | 74.42M | 74.74M |
| Net Cash (Debt) | -119.63M | -101.17M | -43.03M | -63.71M | -20.50M | 71.51M |
| Net Cash Per Share | -1.84 | -1.57 | -0.69 | -1.12 | -0.37 | 1.44 |
| Filing Date Shares Outstanding | 66.05M | 65.06M | 63.59M | 57.94M | 56.41M | 55.69M |
| Total Common Shares Outstanding | 66.01M | 65.01M | 63.50M | 57.82M | 56.26M | 55.58M |
| Working Capital | 68.81M | 67.61M | 88.38M | 64.13M | 54.29M | 121.14M |
| Book Value Per Share | -0.47 | -0.36 | 0.09 | -0.36 | 0.33 | 1.47 |
| Tangible Book Value | -97.80M | -92.35M | -64.44M | -89.01M | -51.31M | 10.04M |
| Tangible Book Value Per Share | -1.48 | -1.42 | -1.01 | -1.54 | -0.91 | 0.18 |
| Machinery | 4.31M | 4.03M | 3.17M | 2.27M | ||
| Leasehold Improvements | 6.40M | 6.10M | 3.57M | 2.21M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -34.33M | -51.64M | -50.42M | -61.69M | -74.41M | -46.81M |
| Depreciation & Amortization | 10.25M | 8.74M | 6.02M | 5.87M | 4.50M | 6.31M |
| Other Amortization | 1.44M | 1.29M | 1.15M | 1.12M | 1.09M | 941.00K |
| Loss (Gain) From Sale of Investments | 272.00K | |||||
| Stock-Based Compensation | 21.02M | 20.70M | 22.25M | 16.46M | 10.83M | 9.58M |
| Provision & Write-off of Bad Debts | 5.70M | 6.51M | 2.45M | 1.44M | 1.60M | 589.00K |
| Other Operating Activities | -3.17M | -5.39M | 7.19M | 8.69M | 5.74M | 7.27M |
| Change in Accounts Receivable | -18.52M | -11.51M | -19.60M | -9.52M | -9.39M | -5.57M |
| Change in Inventory | -1.78M | -11.12M | 3.25M | 4.19M | -10.69M | -2.98M |
| Change in Accounts Payable | 1.18M | 10.10M | 391.00K | -1.02M | 968.00K | -787.00K |
| Change in Other Net Operating Assets | 2.84M | -9.95M | 9.32M | 450.00K | -15.14M | -2.21M |
| Operating Cash Flow | -15.38M | -42.27M | -18.00M | -34.01M | -84.91M | -33.39M |
| Capital Expenditures | -2.90M | -3.44M | -1.47M | -473.00K | -1.62M | -393.00K |
| Sale (Purchase) of Intangibles | -3.62M | -5.01M | -3.35M | -1.15M | -1.32M | -577.00K |
| Investment in Securities | 5.00M | |||||
| Investing Cash Flow | -6.51M | -8.45M | -4.82M | -1.63M | -2.94M | 4.03M |
| Long-Term Debt Issued | 25.00M | 50.00M | 71.96M | |||
| Total Debt Issued | 10.00M | 25.00M | 50.00M | 71.96M | ||
| Short-Term Debt Repaid | -20.00M | |||||
| Long-Term Debt Repaid | -15.00K | -76.32M | ||||
| Total Debt Repaid | -16.00K | -15.00K | -96.32M | |||
| Net Debt Issued (Repaid) | 9.98M | 24.98M | 50.00M | -24.36M | ||
| Issuance of Common Stock | 412.00K | 1.16M | 56.09M | 231.00K | 539.00K | 103.99M |
| Repurchase of Common Stock | -990.00K | -7.00K | ||||
| Other Financing Activities | -4.84M | -8.81M | -7.69M | -5.58M | -4.68M | -6.57M |
| Financing Cash Flow | 5.56M | 17.34M | 47.41M | 44.64M | -4.15M | 73.05M |
| Foreign Exchange Rate Adjustments | -231.00K | 254.00K | -478.00K | -90.00K | -337.00K | |
| Net Cash Flow | -16.57M | -33.13M | 24.11M | 8.92M | -92.33M | 43.69M |
| Free Cash Flow | -18.28M | -45.71M | -19.47M | -34.48M | -86.53M | -33.78M |
| Free Cash Flow Margin | -5.78% | -15.38% | -7.31% | -17.06% | -58.22% | -33.89% |
| Free Cash Flow Per Share | -0.28 | -0.71 | -0.31 | -0.61 | -1.54 | -0.68 |
| Levered Free Cash Flow | -1.82M | -26.70M | -4.68M | -10.38M | -53.74M | -85.52M |
| Unlevered Free Cash Flow | 6.87M | -15.68M | 5.88M | -2.85M | -49.14M | -85.59M |
| Cash Interest Paid | 10.55M | 14.79M | 17.55M | 12.71M | 8.00M | 138.00K |
| Cash Income Tax Paid | 1.13M | 1.22M | 235.00K | 117.00K | 76.00K | 14.00K |
| Change in Working Capital | -16.28M | -22.48M | -6.64M | -5.89M | -34.25M | -11.54M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 485.47M | 431.05M | 699.07M | 608.22M | 422.41M | 361.81M |
| Enterprise Value | 605.10M | 542.42M | 743.91M | 670.98M | 431.35M | 257.75M |
| Last Close Price | 7.35 | 6.65 | 11.04 | 10.53 | 7.51 | 6.51 |
| Forward PE | 172.94 | 57.33 | ||||
| PS Ratio | 1.53 | 1.45 | 2.62 | 3.01 | 2.84 | 3.63 |
| PB Ratio | -18.66 | 126.60 | -29.40 | 22.83 | 4.42 | |
| P/TBV Ratio | 36.03 | |||||
| EV/Sales Ratio | 1.91 | 1.82 | 2.79 | 3.32 | 2.90 | 2.59 |
| Debt / Equity Ratio | -5.33 | -6.71 | 23.54 | -6.12 | 4.02 | 0.91 |
| Net Debt / Equity Ratio | -3.87 | -4.38 | 7.79 | -3.08 | 1.11 | -0.87 |
| Net Debt / EBITDA Ratio | -9.37 | -3.36 | -1.96 | -2.06 | -0.38 | 1.23 |
| Net Debt / FCF Ratio | -6.54 | -2.21 | -2.21 | -1.85 | -0.24 | 2.12 |
| Asset Turnover | 1.33 | 1.30 | 1.26 | 1.10 | 0.68 | 0.43 |
| Inventory Turnover | 3.16 | 5.12 | 7.25 | 4.32 | 5.71 | 17.02 |
| Quick Ratio | 1.09 | 1.44 | 2.14 | 1.93 | 1.64 | 2.79 |
| Current Ratio | 1.70 | 1.90 | 2.40 | 2.33 | 2.17 | 3.10 |
| Return on Equity (ROE) | -148.27% | -1,049.79% | ||||
| Return on Assets (ROA) | -5.68% | -10.25% | -8.08% | -12.30% | -16.53% | -17.04% |
| Return on Capital Employed (ROCE) | -14.50% | -25.00% | -16.10% | -25.70% | -43.80% | -31.80% |
| Earnings Yield | -7.17% | -11.98% | -7.21% | -10.14% | -17.62% | -12.94% |
| FCF Yield | -3.77% | -10.60% | -2.79% | -5.67% | -20.48% | -9.34% |
| Buyback Yield / Dilution | -2.34% | -3.95% | -8.96% | -1.52% | -12.64% | -47.53% |